Drug discovery call for proposals

Alzheimer’s Society and the Alzheimer’s Drug Discovery Foundation is continuing to seek applications that identify and test drug treatments for Alzheimer’s disease and other forms of dementia.

This program will fund clinical studies to measure the safety and tolerability of new drugs for Alzheimer’s or other forms of dementia, as well of proof of efficacy studies with biomarker or cognitive outcomes.

Closing date: 11 May 2018 (Letter of Intent by 13 April)

Visit funding web page